PCI Pharma Services, a biopharmaceutical outsourcing services provider, has announced a number of management updates.
The senior positions include newly created and expanded roles in Strategic Marketing, Program Management, Clinical Services and Global Clinical Quality.
Commenting on the changes, PCI Chief Executive Officer, Salim Haffar, said: “The strategic direction PCI is taking will help us and our clients prepare for the future. We are investing in global infrastructure, innovation, and our leadership to ensure enhanced focus on delivering the best customer experience and solidifying our well-recognised position within the industry. I’m inspired by the strength of our internal management team and our ability to elevate and leverage their talent to launch these new functions and initiatives.”